DUBLIN--(BUSINESS WIRE)--The "Hepatitis Diagnostic Test Market Size, Share & Trends Analysis Report, By Diagnostic Tests (Liver Function, Immunoassays & Nucleic Acid Assays, Imaging, Liver Biopsy), And Segment Forecasts, 2018 - 2025" report has been added to ResearchAndMarkets.com's offering.
Key Findings
- The blood tests segment dominate the market and is expected to exhibit the fastest growth rate over the forecast period owing to their higher adoption as a first line of diagnosis.
- The liver function tests, sub type of blood test hold a significant share of the market since these tests are the first line diagnostics and are prerequisite for further analytical examinations required to performed for confirmation of virus causing the disease
- Some of the major players competing include, but are not limited to Abbott Laboratories, Danaher Corporation, F. Hoffmann Roche, DiaSorin S.p.A, MedMira, Inc., Siemens AG, bioMeriuex SA, Hologic, Inc., and Bio Rad Laboratories.
- These players dominate the market with their strong brand identity and extensive geographic reach by their strategic initiatives such as mergers & acquisition and partnership with other players.
Topics Covered
Chapter 1 Research Methodology
Chapter 2 Executive Summary
Chapter 3 Hepatitis Diagnostic Market Variables, Trends & Scope
Chapter 4 Hepatitis Diagnostic Market: Test Type Estimates & Trend Analysis
Chapter 5 Hepatitis Diagnostic Market: Regional Estimates & Trend Analysis
Chapter 6 Competitive Landscape
- Siemens AG
- Abbott Laboratories
- MedMira Inc.
- Qaigen Inc.
- Beckman Coulter Inc. (Danaher Corporation)
- F. Hoffmann Roche
- Diasorin S.p.A
- bioMeriuex
- Hologic Inc.
- Bio-Rad Laboratories Inc.
For more information about this report visit https://www.researchandmarkets.com/research/29kfg4/global_hepatitis?w=4